Document ID: chunk:federal_register_of_legislation:F2023C00457:reg:9:p2
Version: federal_register_of_legislation:F2023C00457
Segment Type: reg
Provision Reference: reg 9 (pt 2/2)
Character Range: 9095–10904

neurological disorders is defined in the Schedule 1 – Dictionary.

         (14)      taking a drug from the specified list of drugs:
(a)          as prescribed for ongoing use; and
(b)          for at least the 30 days before the clinical worsening of restless legs syndrome;

            Note: specified list of drugs is defined in the Schedule 1 – Dictionary.

         (15)      having multiple sclerosis at the time of the clinical worsening of restless legs syndrome;

         (16)      having smoked tobacco products in an amount of at least 10 pack-years before the clinical worsening of restless legs syndrome, and if smoking has ceased before the clinical worsening of restless legs syndrome, then that worsening occurred within 5 years of cessation;

            Note: one pack-year is defined in the Schedule 1 - Dictionary.

         (17)      being obese for at least the 5 years before the clinical worsening of restless legs syndrome;

            Note: being obese is defined in the Schedule 1 – Dictionary.

         (18)      being pregnant at the time of the clinical worsening of restless legs syndrome;

         (19)      having chronic obstructive pulmonary disease at the time of the clinical worsening of restless legs syndrome;

         (20)      having obstructive sleep apnoea at the time of the clinical worsening of restless legs syndrome;

         (21)      for restless legs syndrome augmentation only, taking a dopaminergic agent including levodopa and pramipexole, or tramadol, for a continuous period of at least the 3 months before the clinical worsening of restless legs syndrome;

            Note: restless legs syndrome augmentation is defined in the Schedule 1 – Dictionary.
(22)      inability to obtain appropriate clinical management for restless legs syndrome.